Destin Vantyle
Physician Assistant · Kingwood, TXNPI 1134779440
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,713 and has fallen 79.2% since, to $357 in 2025.
Across 178 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$743
- AbbVie$714
- Johnson & Johnson$583
- Lundbeck LLC$316
- Otsuka America Pharmaceutical, Inc.$288
- Sunovion Pharmaceuticals Inc.$230
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,963100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $743 |
| AbbVie | 46 | $714 |
| Johnson & Johnson | 10 | $583 |
| Lundbeck LLC | 21 | $316 |
| Otsuka America Pharmaceutical, Inc. | 22 | $288 |
| Sunovion Pharmaceuticals Inc. | 15 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $215 |
| Alkermes, Inc. | 5 | $187 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $175 |
| Neurocrine Biosciences, Inc. | 3 | $138 |
| Vanda Pharmaceuticals Inc. | 6 | $123 |
| Bausch Health US, LLC | 6 | $95 |
| Tris Pharma Inc | 2 | $48 |
| Corium, LLC | 3 | $40 |
| Redhill Biopharma Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$572
- LYBALVI$480
- INVEGA SUSTENNA$254
- INVEGA TRINZA$254
- SPRAVATO$123
- CAPLYTA$109
How this compares
$3,963 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 22 | $738 |
| Trazodone Hcl | 16 | $229 |
| Clonazepam | 26 | $45 |
| Propranolol Hcl | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Kingwood
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.